Okyanos Therapeutics holds the proprietary suite of commercial and investigational technologies that include stem cell isolation devices and consumables, anti-aging therapies and healing amplification solutions. The Therapeutics Division also works with third party regenerative medicine companies via joint partnerships to further enhance revenue growth. Through the rigorous implementation of protocols and acquisition of clinical data, our pipeline of therapeutics can be developed more quickly with collaboration, integrity and transparency.
Tissue Genesis, LLC, (TG) offers best-in-class, enzyme-derived cell therapy processing solutions using high-performance, point-of-care technology that efficiently extracts adult stem cells from autologous adipose tissue in a fully-enclosed and automated process. The Icellator® minimizes cell variability and maximizes yield.
Advanced Regen is a clinical-stage anti-aging company that develops proprietary technologies to promote wellness and extend healthy aging. Our parabiosis-based, core therapeutic platform leverages endogenous factors present in the blood of younger, healthy individuals to treat the aging immune systems of healthy older people, and restore our body's natural defenses against infection and disease.
ParaXome is a healing amplification solution based on a novel stem cell therapy for myocardial tissue repair and restoration of cardiac function. It uses a natural enzyme, known as CAMKK1, to regulate and enhance mesenchymal stem cell (MSC) paracrine signaling through improvement of exosome generation and activity.